These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37961739)

  • 1. Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing.
    Xiang S; Lawrence PJ; Peng B; Chiang C; Kim D; Shen L; Ning X
    ArXiv; 2023 Oct; ():. PubMed ID: 37961739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing.
    Xiang S; Lawrence PJ; Peng B; Chiang C; Kim D; Shen L; Ning X
    Pac Symp Biocomput; 2024; 29():306-321. PubMed ID: 38160288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-based stage-specific drug repurposing for Alzheimer's disease.
    Savva K; Zachariou M; Bourdakou MM; Dietis N; Spyrou GM
    Comput Struct Biotechnol J; 2022; 20():1427-1438. PubMed ID: 35386099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing for Alzheimer's disease from 2012-2022-a 10-year literature review.
    Grabowska ME; Huang A; Wen Z; Li B; Wei WQ
    Front Pharmacol; 2023; 14():1257700. PubMed ID: 37745051
    [No Abstract]   [Full Text] [Related]  

  • 5. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease.
    Wu Q; Su S; Cai C; Xu L; Fan X; Ke H; Dai Z; Fang S; Zhuo Y; Wang Q; Pan H; Gu Y; Fang J
    Comput Struct Biotechnol J; 2023; 21():1907-1920. PubMed ID: 36936813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
    Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
    J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating new drug repurposing hypotheses using disease-specific hypergraphs.
    Jain A; Charpignon ML; Chen IY; Philippakis A; Alaa A
    Pac Symp Biocomput; 2024; 29():261-275. PubMed ID: 38160285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Drug Repurposing for Alzheimer's Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies.
    Xu Y; Kong J; Hu P
    Front Pharmacol; 2021; 12():617537. PubMed ID: 34276354
    [No Abstract]   [Full Text] [Related]  

  • 10. A drug repurposing method based on inhibition effect on gene regulatory network.
    Li X; Liao M; Wang B; Zan X; Huo Y; Liu Y; Bao Z; Xu P; Liu W
    Comput Struct Biotechnol J; 2023; 21():4446-4455. PubMed ID: 37731599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
    G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
    Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
    Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
    Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer's Disease in Real-World Clinical Datasets.
    Yan C; Grabowska ME; Dickson AL; Li B; Wen Z; Roden DM; Stein CM; Embí PJ; Peterson JF; Feng Q; Malin BA; Wei WQ
    medRxiv; 2023 Jul; ():. PubMed ID: 37461512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer's Disease in Real-World Clinical Datasets.
    Wei WQ; Yan C; Grabowska M; Dickson A; Li B; Wen Z; Roden D; Stein C; Embí P; Peterson J; Feng Q; Malin B
    Res Sq; 2023 Jul; ():. PubMed ID: 37503019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validation.
    Yan C; Grabowska ME; Dickson AL; Li B; Wen Z; Roden DM; Michael Stein C; Embí PJ; Peterson JF; Feng Q; Malin BA; Wei WQ
    NPJ Digit Med; 2024 Feb; 7(1):46. PubMed ID: 38409350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network.
    Yang J; Li Z; Wu WKK; Yu S; Xu Z; Chu Q; Zhang Q
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36347526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach.
    Advani D; Kumar P
    ACS Omega; 2021 Jun; 6(21):13870-13887. PubMed ID: 34095679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.
    Fang J; Zhang P; Wang Q; Chiang CW; Zhou Y; Hou Y; Xu J; Chen R; Zhang B; Lewis SJ; Leverenz JB; Pieper AA; Li B; Li L; Cummings J; Cheng F
    Alzheimers Res Ther; 2022 Jan; 14(1):7. PubMed ID: 35012639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoepidemiology evaluation of bumetanide as a potential candidate for drug repurposing for Alzheimer's disease.
    Morales J; Gabriel N; Natarajan L; LaCroix AZ; Shadyab AH; Xu R; Silverman J; Feldman HH; Hernandez I;
    Alzheimers Dement; 2024 Jun; ():. PubMed ID: 39030734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-faceted therapeutic strategy for treatment of Alzheimer's disease by concurrent administration of etodolac and α-tocopherol.
    Elfakhri KH; Abdallah IM; Brannen AD; Kaddoumi A
    Neurobiol Dis; 2019 May; 125():123-134. PubMed ID: 30710675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.